Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins

Peptides

Volumn 23, Issue 7, 2002, Pages 1343-1350

  Atwood, Craig S ^a   Martins, Ralph N ^b   Smith, Mark A ^a   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alzheimer disease; Amyloid; A ; Composition; Down syndrome; Inflammation; Metal ions; Microglial activation; Oxidants; Oxidative stress; Posttranslational modification; Protein crosslinks

Indexed keywords

4 HYDROXYNONENAL; ACETYLCHOLINESTERASE; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; AMYLOID P COMPONENT; APOLIPOPROTEIN E; CATALASE; CERULOPLASMIN; CHEMOKINE; CHOLINESTERASE; CHONDROITIN; CLUSTERIN; COMPLEMENT; COMPLEMENT INHIBITOR; CYSTATIN C; CYTOKINE; DERMATAN SULFATE; FERRITIN; HEPARAN; IMMUNOGLOBULIN; KERATIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; METAL ION; MYELOPEROXIDASE; PENTOSIDINE; SUPEROXIDE DISMUTASE; TYROSINE; UBIQUITIN; UNINDEXED DRUG; BIOLOGICAL MARKER; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CROSS LINKING; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SENILE PLAQUE; AMYLOIDOSIS; ANIMAL; CHEMISTRY; HIPPOCAMPUS; METABOLISM; MICROGLIA; NERVE CELL; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN PROCESSING; RESPIRATORY BURST; REVIEW;

AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; BIOLOGICAL MARKERS; HIPPOCAMPUS; HUMANS; MICROGLIA; NEURONS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; RESPIRATORY BURST; SENILE PLAQUES;

EID: 0035997249     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00070-0     Document Type: Review

References (157)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. The isolation and amino acid composition of senile plaque core protein
3. Factors affecting pro- and anti-oxidant properties of fragments of the (β-protein precursor (βPP): Implication for Alzheimer's disease
4. Copper-mediated aggregation and polymerization of Aβ
5. The role of free radicals and metal ions in the pathogenesis of Alzheimer's disease
6. Human amyloid-derived Aβ contains tyrosine cross-linked oligomers
7. Copper-catalyzed oxidation of Alzheimer Aβ
8. Characterization of copper interactions with Alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta-42
9. Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits
10. Copper mediated crosslinking reactions of Alzheimers' Amyloid-β
11. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
12. A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques
13. Two-dimensional structure of beta-amyloid (10-35) fibrils
14. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
15. Alzheimer Aβ functions as a superoxide antioxidant in vitro
16. Aluminosilicates and senile plaque formation in Alzheimer's disease
17. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue
18. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
19. Perlecan binds to the beta-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability
20. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: Evidence for a neuronal origin
21. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
22. Anti-apoptotic action of Alzheimer Aβ
23. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion
24. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation
25. Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J)
26. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy
27. β-Amyloid converts an acute phase injury response to chronic injury responses
28. Neuronal and microglial involvement in β-amyloid protein deposition in Alzheimer's disease
29. Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease
30. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc
31. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: Prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques
32. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins
33. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease
34. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease
35. Immunodetection of the amyloid P component in Alzheimer's disease
36. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation
37. Amyloidogenicity of rodent and human beta A4 sequences
38. The sequence of neuroimmunological events in cerebral amyloid plaque formation in Alzheimer's disease
39. Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins
40. Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Aβ) dimer in the cortex during aging
41. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1
42. Release of ovoperoxidase from sea urchin eggs hardens the fertilization membrane with tyrosine crosslinks
43. Microglial response to amyloid plaques in APPsw transgenic mice
44. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus
45. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation
46. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease
47. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain
48. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
49. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
50. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
51. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
52. Evidence of neuronal oxidative damage in Alzheimer's disease
53. Alzheimer's disease: A clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis
54. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
55. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia
56. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic beta-protein fragments
57. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease?
58. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
59. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease
60. Identification of a novel aspartic protease (Asp 2) as beta-secretase
61. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
62. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique
63. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
64. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic
65. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: Implications for leakage across the blood-brain barrier in Alzheimer's disease
66. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders
67. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects
68. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease
69. Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease
70. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
71. Amyloid-β is a physiological antioxidant for lipoproteins in cerebrospinal fluid and plasma
72. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
73. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains
74. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide
75. A familial Alzheimer's disease locus on chromosome 1
76. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state
77. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
78. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
79. Copper, iron and zinc in Alzheimer's disease senile plaques
80. Role of microglia in senile plaque formation
81. Brain amyloid - A physicochemical perspective
82. The role of microglial cells in plaque formation in Alzheimer's disease
83. Brain trace elements in Alzheimer disease
84. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
85. Amyloid plaque core protein in Alzheimer disease and Down syndrome
86. Activation of the classical complement pathway in brain tissue of Alzheimer patients
87. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles
88. Ubiquitin is a component of paired helical filaments in Alzheimer's disease
89. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease
90. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease
91. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
92. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein
93. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging
94. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome
95. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome
96. Oxidative damage is the earliest event in Alzheimer disease
97. Immunohistochemical evidence of oxidative stress in Alzheimer's disease
98. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease
99. Senile plaques and neurofibrillary tangles: What role do they play in Alzheimer's disease?
100. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains
101. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
102. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture
103. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red
104. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease
105. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
106. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
107. BetaA4 amyloid protein deposition in brain after head trauma
108. Most amyloid plaques contain ferritin-rich cells
109. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
110. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease
111. Morphology and toxicity of Aβ-β1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
112. Redox-active iron mediates amyloid-β toxicity
113. Dominant and differential deposition of distinct beta-amyloid peptide species, Aβ N3(pE), in senile plaques
114. Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain
115. Microglial activation in early stages of amyloid beta protein deposition
116. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
117. Amyloid beta protein (Aβ) removal by neuroglial cells in culture
118. Neuritic plaque amyloid in Alzheimer's disease is highly racemized
119. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution
120. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: Implications for its role in plaque progression
121. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation
122. Production of the Alzheimer amyloid beta protein by normal proteolytic processing
123. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease
124. Processing of the beta-amyloid precursor: Multiple proteases generate and degrade potentially amyloidogenic fragments
125. Purification and cloning of amyloid precursor protein beta-secretase from human brain
126. Candida albicans cell walls contain the fluorescent crosslinking amino acid dityrosine
127. Alzheimer disease
128. 1-Trypsin immunoreactivity in Alzheimer disease
129. Proteolytic anomalies in Alzheimer disease
130. Advanced Maillard reaction products are associated with Alzheimer disease pathology
131. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
132. Widespread peroxynitrite-mediated damage in Alzheimer's disease
133. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
134. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
135. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses
136. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease
137. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease
138. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain
139. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease
140. Association of microglia with amyloid plaques in brains of APP23 transgenic mice
141. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
142. Molecular and cellular mediators of Alzheimer's disease inflammation
143. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
144. Iron and ferritin in the neuritic plaques of Alzheimer disease
145. Protein, nucleotide, genome, OMIM amyloid beta protein gene: CDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
146. N-Terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits
147. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
148. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
149. The structure of neuritic plaque in the cerebral cortex of aged rats
150. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease
151. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy
152. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
153. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines
154. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
155. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
156. NACP the precursor protein of the non-amyloid beta/A4 protein (Aβ) component of Alzheimer disease amyloid, binds A beta and stimulates Aβ aggregation